Last week, Phadia US Inc. announced that the U.S. Food and Drug Administration had cleared EliA (TM) CCP, the first fully automated assay for measuring cyclic citrullinated peptide (CCP) antibodies. CCP is an indicator for rheumatoid arthritis (RA...